Related Experiment Video
Updated: May 8, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study
1Center for High Performance Computing, Institute of Advanced Computing and Digital Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Boulevard, University Town of Shenzhen, Xili Nanshan, Shenzhen 518055, China, Department of Chemistry and Institutes of Molecular Technology for Drug Discovery and Synthesis, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Abstract:
Topoisomerase IB (Top1) inhibitors, such as camptothecin (CPT), stabilize the Top1-DNA cleavage complex in a DNA sequence-dependent manner. The sequence selectivity of Top1 inhibitors is important for targeting specific genomic sequences of therapeutic value. However, the molecular mechanisms underlying this selectivity remain largely unknown. We performed molecular dynamics simulations to delineate structural, dynamic and energetic features that contribute to the differential sequence selectivity of the Top1 inhibitors. We found the sequence selectivity of CPT to be highly correlated with the drug binding energies, dynamic and structural properties of the linker domain. Chemical insights, gained by per-residue binding energy analysis revealed that the non-polar interaction between CPT and nucleotide at the +1 position of the cleavage site was the major (favorable) contributor to the total binding energy. Mechanistic insights gained by a potential of mean force analysis implicated that the drug dissociation step was associated with the sequence selectivity. Pharmaceutical insights gained by our molecular dynamics analyses explained why LMP-776, an indenoisoquinoline derivative under clinical development at the National Institutes of Health, displays different sequence selectivity when compared with camptothecin and its clinical derivatives.
Insights
Topoisomerase I (Top1) inhibitors show sequence selectivity, crucial for therapeutic targeting. Molecular dynamics revealed drug binding energies and linker domain dynamics drive this selectivity, with specific nucleotide interactions being key.
Area of Science:
- Molecular Biology
- Biochemistry
- Computational Chemistry
Background:
- Topoisomerase I (Top1) inhibitors, like camptothecin (CPT), stabilize the Top1-DNA cleavage complex.
- The sequence selectivity of these inhibitors is vital for targeting specific therapeutic genomic sites.
- Underlying molecular mechanisms of Top1 inhibitor sequence selectivity are not well understood.
Purpose of the Study:
- To elucidate the structural, dynamic, and energetic factors contributing to Top1 inhibitor sequence selectivity.
- To understand the molecular basis for differential sequence selectivity among Top1 inhibitors.
Main Methods:
- Molecular dynamics (MD) simulations were employed to analyze Top1 inhibitor-DNA interactions.
- Per-residue binding energy analysis was used to identify key molecular interactions.
- Potential of Mean Force (PMF) analysis investigated drug dissociation mechanisms.
Main Results:
- CPT sequence selectivity strongly correlates with drug binding energies and linker domain dynamics.
- Non-polar interactions between CPT and the +1 nucleotide significantly contribute to binding energy.
- Drug dissociation, analyzed via PMF, is implicated in sequence selectivity.
Conclusions:
- Molecular dynamics simulations reveal key determinants of Top1 inhibitor sequence selectivity.
- Understanding these mechanisms aids in explaining differential selectivity, such as between CPT and LMP-776.
- This research provides a foundation for designing more targeted Top1 inhibitor therapies.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Inhibitors of Bacterial DNA Synthesis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
DNA Helicases

